Role of enzyme-treated cells in RBC anti
β
Jocelyne Conne; Philippe Schneider; Jean-Daniel Tissot
π
Article
π
2007
π
John Wiley and Sons
π
English
β 306 KB
The role of enzyme-treated cells (ETCs) in red blood cell (RBC) antibody screening has been the subject of controversy, and its place in the clinical routine remains to be determined. In this work, plasma samples containing anti-RH1 (anti-D; N 5 10), anti-RH2 (anti-C; N 5 10), or anti-RH3 (anti-E; N